Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Return on Equity (2016 - 2025)

Historic Return on Equity for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 7.3%.

  • Jaguar Health's Return on Equity fell 47200.0% to 7.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.3%, marking a year-over-year decrease of 47200.0%. This contributed to the annual value of 6.89% for FY2024, which is 167700.0% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Return on Equity is 7.3%, which was down 47200.0% from 10.74% recorded in Q2 2025.
  • Jaguar Health's 5-year Return on Equity high stood at 1.34% for Q2 2021, and its period low was 43.15% during Q4 2022.
  • In the last 5 years, Jaguar Health's Return on Equity had a median value of 6.75% in 2023 and averaged 9.03%.
  • In the last 5 years, Jaguar Health's Return on Equity plummeted by -400000bps in 2022 and then skyrocketed by 298800bps in 2023.
  • Jaguar Health's Return on Equity (Quarter) stood at 3.15% in 2021, then tumbled by -1270bps to 43.15% in 2022, then soared by 69bps to 13.27% in 2023, then soared by 70bps to 4.01% in 2024, then tumbled by -82bps to 7.3% in 2025.
  • Its Return on Equity stands at 7.3% for Q3 2025, versus 10.74% for Q2 2025 and 11.05% for Q1 2025.